Company page

Fujian Haixi Pharmaceuticals Co., Ltd. Class H

Fujian Haixi Pharmaceuticals Co., Ltd. Class H, trading under the ticker 2637 on the Hong Kong market, has a market capitalization of approximately HKD 2.33 billion. The company specializes in the pharmaceutical industry, focusing on the development and production of various healthcare products. As a publicly listed entity, it is subject to the regulatory requirements of the Hong Kong Stock Exchange.

profile2637AI content: aiUpdated May 29, 2026/company/fujian-haixi-pharms-co-ltd
Fujian Haixi Pharmaceuticals Co., Ltd. Class H logo
Ticker
2637
Market cap
$2.33B
Sector
Health Technology
Industry
Biotechnology